Rapport Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Rapport Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About RAPP

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. 

CEO
Abraham N. Ceesay
CEOAbraham N. Ceesay
Employees
69
Employees69
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2022
Founded2022
Employees
69
Employees69

RAPP Key Statistics

Market cap
1.33B
Market cap1.33B
Price-Earnings ratio
-11.75
Price-Earnings ratio-11.75
Dividend yield
—
Dividend yield—
Average volume
378.06K
Average volume378.06K
High today
$29.19
High today$29.19
Low today
$26.46
Low today$26.46
Open price
$26.77
Open price$26.77
Volume
408.87K
Volume408.87K
52 Week high
$42.27
52 Week high$42.27
52 Week low
$6.43
52 Week low$6.43

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own RAPP. This list is generated using Robinhood data, and it’s not a recommendation.
D-Wave Quantum
Rigetti Computing
Marvell Technology
SoundHound AI
Quantum Computing
Applied Digital
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.